Literature DB >> 9500350

Membranous nephropathy: an IgG4-mediated disease.

D B Oliveira1.   

Abstract

Membranous nephropathy is characterised by the deposition of immunoglobulin, predominantly of the IgG4 subclass, along the epithelial surface of the glomerular-basement membrane. Current models of pathogenesis usually assume in-situ immune-complex formation involving an as yet uncharacterised fixed glomerular antigen. I argue that the properties of IgG4 (inability to fix complement and therefore impaired clearance of IgG4-containing complexes; low affinity and therefore ability for IgG4-containing complexes to dissociate and traverse the glomerular-basement membrane) are compatible with a pathogenic mechanism that involves the deposition of circulating IgG4 immune complexes containing diverse antigens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500350     DOI: 10.1016/S0140-6736(97)04122-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.

Authors:  Jun-Jun Zhang; Mahdi Malekpour; Wentian Luo; Linna Ge; Florina Olaru; Xu-Ping Wang; Maimouna Bah; Yoshikazu Sado; Laurence Heidet; Sandra Kleinau; Agnes B Fogo; Dorin-Bogdan Borza
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

2.  Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).

Authors:  H Wakui; H Imai; A Komatsuda; A B Miura
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.

Authors:  Tomohiro Kaneko; Akira Shimizu; Michiko Aoki; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2014-07-18

4.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

Review 5.  Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.

Authors:  Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

6.  Mouse models of membranous nephropathy: the road less travelled by.

Authors:  Dorin-Bogdan Borza; Jun-Jun Zhang; Laurence H Beck; Catherine Meyer-Schwesinger; Wentian Luo
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

7.  Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses.

Authors:  P D Kiely; M R Helbert; J Miles; D B Oliveira
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

8.  Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy.

Authors:  Chia-Chao Wu; Kuo-Cheng Lu; Yuh-Feng Lin; Jin-Shuen Chen; Ching-Feng Huang; Chun-Chi Chen; Shih-Hua Lin; Pauling Chu; Huey-Kang Sytwu
Journal:  J Clin Immunol       Date:  2011-11-15       Impact factor: 8.317

9.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

10.  Pathophysiological lessons from rare associations of immunological disorders.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.